United States · FDA National Drug Code directory

Asthma Therapy

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 17312-017_4604ca9e-7244-adfd-e063-6394a90afa65
Product NDC: 17312-017
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR -
Labeler: TRP Company
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20111201
Source listing expiry: 20261231

Source-listed ingredients

STRYCHNOS NUX-VOMICA SEED — 6 [hp_C]/1
ASPIDOSPERMA QUEBRACHO-BLANCO BARK — 6 [hp_C]/1
SULFUR — 6 [hp_C]/1
ARSENIC TRIOXIDE — 6 [hp_C]/1
HISTAMINE DIHYDROCHLORIDE — 6 [hp_C]/1
DERMATOPHAGOIDES PTERONYSSINUS — 6 [hp_C]/1
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE — 6 [hp_C]/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE in 1 PACKAGE (17312-017-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · 17312-017-14

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →